NO930649L - Maalkomponent-maaling - Google Patents

Maalkomponent-maaling

Info

Publication number
NO930649L
NO930649L NO93930649A NO930649A NO930649L NO 930649 L NO930649 L NO 930649L NO 93930649 A NO93930649 A NO 93930649A NO 930649 A NO930649 A NO 930649A NO 930649 L NO930649 L NO 930649L
Authority
NO
Norway
Prior art keywords
target components
sample
liposomes
antibodies
target component
Prior art date
Application number
NO93930649A
Other languages
English (en)
Norwegian (no)
Other versions
NO930649D0 (no
Inventor
Robert A Levine
Stephen C Wardlaw
Rodolfo Rodriguez
Judith Britz
Thomas J Mercolino
Original Assignee
Robert A Levine
Stephen C Wardlaw
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert A Levine, Stephen C Wardlaw, Becton Dickinson Co filed Critical Robert A Levine
Publication of NO930649D0 publication Critical patent/NO930649D0/no
Publication of NO930649L publication Critical patent/NO930649L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/5375—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by changing the physical or chemical properties of the medium or immunochemicals, e.g. temperature, density, pH, partitioning
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO93930649A 1992-02-25 1993-02-24 Maalkomponent-maaling NO930649L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84197692A 1992-02-25 1992-02-25

Publications (2)

Publication Number Publication Date
NO930649D0 NO930649D0 (no) 1993-02-24
NO930649L true NO930649L (no) 1993-08-26

Family

ID=25286232

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93930649A NO930649L (no) 1992-02-25 1993-02-24 Maalkomponent-maaling

Country Status (17)

Country Link
US (1) US5593848A (cg-RX-API-DMAC7.html)
EP (1) EP0557595B1 (cg-RX-API-DMAC7.html)
JP (1) JP2925105B2 (cg-RX-API-DMAC7.html)
CN (1) CN1091521A (cg-RX-API-DMAC7.html)
AT (1) ATE155889T1 (cg-RX-API-DMAC7.html)
AU (1) AU662571B2 (cg-RX-API-DMAC7.html)
BR (1) BR9300639A (cg-RX-API-DMAC7.html)
CA (1) CA2090282A1 (cg-RX-API-DMAC7.html)
DE (1) DE69221118T2 (cg-RX-API-DMAC7.html)
DK (1) DK0557595T3 (cg-RX-API-DMAC7.html)
ES (1) ES2106121T3 (cg-RX-API-DMAC7.html)
FI (1) FI930821L (cg-RX-API-DMAC7.html)
GR (1) GR3024970T3 (cg-RX-API-DMAC7.html)
MX (1) MX9300965A (cg-RX-API-DMAC7.html)
NO (1) NO930649L (cg-RX-API-DMAC7.html)
RU (1) RU2116068C1 (cg-RX-API-DMAC7.html)
TW (1) TW246716B (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342790A (en) * 1992-10-30 1994-08-30 Becton Dickinson And Company Apparatus for indirect fluorescent assay of blood samples
AU4101697A (en) * 1996-11-22 1998-05-28 Robert A. Levine Process for enhancing the aggregation and/or agglutination of erythrocytes prior to centrifugation
US6197523B1 (en) 1997-11-24 2001-03-06 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood
AU9233698A (en) * 1997-11-22 1999-06-17 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer cells and/or hematologic progenitor cells in whole blood
US6911315B2 (en) * 1997-11-24 2005-06-28 David L. Rimm Method for the detection, identification, enumeration and confirmation of virally infected cells and other epitopically defined cells in whole blood
YU78600A (sh) * 1998-06-26 2002-11-15 Pfizer Products Inc. Poboljšani postupak dobijanja adukta schiff-ove baze amina sa 0-hidroksi aldehidima i na njima baziranih formulacija materijala
GB0021303D0 (en) * 2000-08-30 2000-10-18 Medinnova Sf Use
EP1576126A3 (en) * 2002-10-30 2005-10-26 Pointilliste, Inc. Systems for capture and analysis of biological particles and methods using the systems
JP2007528854A (ja) * 2003-07-09 2007-10-18 カリフォルニア パシフィック メディカル センター 細胞への物質送達の遠隔検出
US7996825B2 (en) * 2003-10-31 2011-08-09 Hewlett-Packard Development Company, L.P. Cross-file inlining by using summaries and global worklist
US20060018911A1 (en) * 2004-01-12 2006-01-26 Dana Ault-Riche Design of therapeutics and therapeutics
CA2720299C (en) * 2008-04-02 2015-02-17 Abbott Point Of Care, Inc. Self-calibrating gradient dilution in a constituent assay and gradient dilution apparatus performed in a thin film sample
WO2009126505A1 (en) * 2008-04-09 2009-10-15 Abbott Point Of Care, Inc. Method of detecting very low levels of analyte within a thin film fluid sample contained in a thin thickness chamber
FR2965273B1 (fr) * 2010-09-29 2015-07-17 Centre Nat Rech Scient Procede de preparation d'une structure chimique presentant une partition de phases, apte a generer un spectre de fluorescence specifique et ses applications
US9624474B2 (en) 2010-12-01 2017-04-18 Samsung Electronics Co, Ltd. Method of separating target cell in biological sample
CN102788879B (zh) * 2011-05-20 2015-04-01 常州康卫生物技术有限公司 一种生物检测试剂
CA2985135A1 (en) * 2015-05-06 2016-11-10 Seracare Life Sciences, Inc. Liposomal preparations for non-invasive-prenatal or cancer screening

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862303A (en) * 1972-02-02 1975-01-21 Atomic Energy Commission Method for rapid detection and identification of serological factors
US4027660A (en) * 1976-04-02 1977-06-07 Wardlaw Stephen C Material layer volume determination
US4181609A (en) * 1977-12-20 1980-01-01 Levine Robert A Blood constituents testing method
US4342739A (en) * 1979-01-09 1982-08-03 Fuji Photo Film Co., Ltd. Novel material for immunological assay of biochemical components and a process for the determination of said components
US4332785A (en) 1980-04-09 1982-06-01 University Patents, Inc. Immunoassay for measurement of reticulocytes, and immunoreactive reagents for use therein
IL64878A (en) * 1982-01-27 1986-01-31 Yissum Res Dev Co Method for detection of and determination of malaria antibodies and malaria antigens in human blood
JPS5984162A (ja) * 1982-11-05 1984-05-15 Toshiba Corp 免疫分析法
US4591570A (en) * 1983-02-02 1986-05-27 Centocor, Inc. Matrix of antibody-coated spots for determination of antigens
JPS6035267A (ja) * 1983-08-05 1985-02-23 Fuji Photo Film Co Ltd 多項目免疫検査法
US5011771A (en) * 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
FR2571498B1 (fr) * 1984-10-04 1988-04-08 Immunotech Sa Procede de separation de cellules utilisant des anticorps et des billes de faible densite
EP0241042A3 (en) * 1986-04-11 1988-05-04 Hitachi, Ltd. A method for cell analysis
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
GB2200448B (en) * 1987-01-23 1991-01-16 Univ London Targetted liposomes and their use in immunoassay
US5017472A (en) * 1987-09-09 1991-05-21 Bankert Richard B Microflotation devices used for immunoassays and cell/molecular fractionation
US4978625A (en) * 1987-10-19 1990-12-18 Becton, Dickinson And Company Fluorescence immunoassay using water insoluble dyes
GB2239197B (en) * 1989-12-22 1993-10-06 Syntex Inc Method for separating components in a mixture
JPH03249561A (ja) * 1990-02-28 1991-11-07 Toshiba Corp 免疫分析試薬

Also Published As

Publication number Publication date
ES2106121T3 (es) 1997-11-01
EP0557595A3 (cg-RX-API-DMAC7.html) 1993-11-10
BR9300639A (pt) 1993-08-31
TW246716B (cg-RX-API-DMAC7.html) 1995-05-01
FI930821A7 (fi) 1993-08-26
DE69221118T2 (de) 1998-02-26
NO930649D0 (no) 1993-02-24
RU2116068C1 (ru) 1998-07-27
AU662571B2 (en) 1995-09-07
CA2090282A1 (en) 1993-08-26
DK0557595T3 (da) 1997-12-29
GR3024970T3 (en) 1998-01-30
JP2925105B2 (ja) 1999-07-28
JPH0821833A (ja) 1996-01-23
CN1091521A (zh) 1994-08-31
US5593848A (en) 1997-01-14
MX9300965A (es) 1994-08-31
EP0557595A2 (en) 1993-09-01
FI930821A0 (fi) 1993-02-24
EP0557595B1 (en) 1997-07-23
DE69221118D1 (de) 1997-09-04
FI930821L (fi) 1993-08-26
AU2983692A (en) 1993-08-26
ATE155889T1 (de) 1997-08-15

Similar Documents

Publication Publication Date Title
NO930649L (no) Maalkomponent-maaling
DK0692097T3 (da) Anordning til chromatografisk bestemmelse, der indeholder modsatstillede dele
NZ306051A (en) Testing using electrochemiluminescence
CA2336985A1 (en) Method of glucose or galactose detection with glucose/galactose binding protein
CA2103052A1 (en) Assay device
DK1000345T3 (da) Fremgangsmåde og apparat til dannelse af referencer for fluorescensintensitetssignaler
EP0805215A3 (en) Diagnostic methods and probes
DE68928994D1 (de) Elektrochemilumineszente testverfahren
CA2218008A1 (en) Use of thermochromic liquid crystals in reflectometry based diagnostic methods
EP0311768A3 (en) Immunosensor
AU3916493A (en) Fast response test panel
DK314987A (da) Fremgangsmaade til specifik bestemmelse af serumfructosaminindhold samt hertil egnet reagensblanding
DE69019647D1 (de) Optische sonde zum nachweis von lichtübertragenden eigenschaften.
RU93004564A (ru) Модифицирующая удельный вес маркерная частица, способ анализа пробы биологической жидкости, применение маркерной частицы в анализе пробы биологической жидкости
AU5572998A (en) Improving performance of binding assays by use of more than one label
SE8801011L (sv) Foerfarande foer bestaemning av koncentrationen av en luminiscerande
US4187075A (en) Method of analyzing biological, liquid specimens for antigens or antibodies
WO1989007757A3 (en) Fluorimeters
SU670857A1 (ru) Образец дл определени прочности сцеплени слоев биметаллического соединени
ATE208041T1 (de) A-protein als diagnostikum für krebs
ATE118617T1 (de) Enzym-quantifizierungstest auf einem docht.
SMITH Evaluation of sensitized fluorescence for polynuclear aromatic hydrocarbon detection(in combustion products)[Final Report, Jan.- Jun. 1979]
DE3786351D1 (de) Festphasenimmunoassayverfahren.
Smith Evaluation of Sensitized Fluorescence for Polynuclear Aromatic Hydrocarbon Detection
Murata et al. An approach towards a high sensitivity detection method for brevetoxins